Prostate Cancer Therapeutics Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Prostate Cancer Therapeutics Market to 2027 - Global Analysis and Forecasts By Therapy ( Hormonal Therapy, Chemotherapy, Targeted Therapy, Immunotherapy ); Distribution Channel ( Hospitals, Specialty Clinics, Others )

Report Code: TIPRE00003423 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
MARKET INTRODUCTION
Prostate cancer is diagnosed when cells in the prostate gland start to grow abnormally and uncontrollably. The prostate is a gland which is only present in males that makes some of the fluid that is a part of semen. The prostate cancer can be treated by surgery, radiation, hormone therapy, chemotherapy and others. The treatment for the prostate cancer is decided by the stages of the cancer. The professionals such as urologists, radiation oncologists and medical oncologists are the people who treat prostate cancer.

MARKET DYNAMICS
The prostate cancer therapeutics market is anticipated to grow in the forecast period owing to driving factors such as rising prevalence of prostate cancer growing majorly in North America and Asia Pacific and other regions. The rising geriatric population across the world is leading the growth of market during the forecast period. The growing advancement in the healthcare and developments in the oncology are likely to create growth opportunities during the forecast period.

MARKET SCOPE
The "Global Prostate Cancer Therapeutics Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of prostate cancer therapeutics market with detailed market segmentation by therapy, distribution channel and geography. The global prostate cancer therapeutics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading prostate cancer therapeutics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global prostate cancer therapeutics market is segmented on the basis of therapy area and distribution channel. On the basis of the therapy the segment is classified as hormonal therapy, chemotherapy, targeted therapy and immunotherapy. On the basis of the distribution channel segment is divided into hospitals, specialty clinics and others.


REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global prostate cancer therapeutics market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The prostate cancer therapeutics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting prostate cancer therapeutics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the prostate cancer therapeutics market in these regions.


MARKET PLAYERS

The reports cover key developments in the prostate cancer therapeutics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from prostate cancer therapeutics market are anticipated to lucrative growth opportunities in the future with the rising demand for prostate cancer therapeutics market in the global market. Below mentioned is the list of few companies engaged in the prostate cancer therapeutics market.

The report also includes the profiles of key prostate cancer therapeutics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

• Valent Pharmaceuticals LLC
• Bayer AG
• Astrazeneca
• Sanofi Aventis
• IPSEN
• Bristol-Myers Squibb
• Astellas Pharma Inc
• Pfizer Inc
• Teva Pharmaceutical Industries Ltd
• Abbott Laboratories

The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Prostate Cancer Therapeutics Market - By Therapy
1.3.2 Prostate Cancer Therapeutics Market - By Distribution Channel
1.3.3 Prostate Cancer Therapeutics Market - By Region
1.3.3.1 By Country

2. KEY TAKEWAYS

3. RESEARCH METHODOLOGY

4. PROSTATE CANCER THERAPEUTICS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. PROSTATE CANCER THERAPEUTICS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. PROSTATE CANCER THERAPEUTICS MARKET - GLOBAL MARKET ANALYSIS
6.1. PROSTATE CANCER THERAPEUTICS - GLOBAL MARKET OVERVIEW
6.2. PROSTATE CANCER THERAPEUTICS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. PROSTATE CANCER THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - THERAPY
7.1. OVERVIEW
7.2. THERAPY MARKET FORECASTS AND ANALYSIS
7.3. HORMONAL THERAPY
7.3.1. Overview
7.3.2. Hormonal Therapy Market Forecast and Analysis
7.4. CHEMOTHERAPY
7.4.1. Overview
7.4.2. Chemotherapy Market Forecast and Analysis
7.5. TARGETED THERAPY
7.5.1. Overview
7.5.2. Targeted Therapy Market Forecast and Analysis
7.6. IMMUNOTHERAPY
7.6.1. Overview
7.6.2. Immunotherapy Market Forecast and Analysis

8. PROSTATE CANCER THERAPEUTICS MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITALS
8.3.1. Overview
8.3.2. Hospitals Market Forecast and Analysis
8.4. SPECIALTY CLINICS
8.4.1. Overview
8.4.2. Specialty Clinics Market Forecast and Analysis
8.5. OTHERS
8.5.1. Overview
8.5.2. Others Market Forecast and Analysis

9. PROSTATE CANCER THERAPEUTICS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Prostate Cancer Therapeutics Market Overview
9.1.2 North America Prostate Cancer Therapeutics Market Forecasts and Analysis
9.1.3 North America Prostate Cancer Therapeutics Market Forecasts and Analysis - By Therapy
9.1.4 North America Prostate Cancer Therapeutics Market Forecasts and Analysis - By Distribution Channel
9.1.5 North America Prostate Cancer Therapeutics Market Forecasts and Analysis - By Countries
9.1.5.1 United States Prostate Cancer Therapeutics Market
9.1.5.1.1 United States Prostate Cancer Therapeutics Market by Therapy
9.1.5.1.2 United States Prostate Cancer Therapeutics Market by Distribution Channel
9.1.5.2 Canada Prostate Cancer Therapeutics Market
9.1.5.2.1 Canada Prostate Cancer Therapeutics Market by Therapy
9.1.5.2.2 Canada Prostate Cancer Therapeutics Market by Distribution Channel
9.1.5.3 Mexico Prostate Cancer Therapeutics Market
9.1.5.3.1 Mexico Prostate Cancer Therapeutics Market by Therapy
9.1.5.3.2 Mexico Prostate Cancer Therapeutics Market by Distribution Channel
9.2. EUROPE
9.2.1 Europe Prostate Cancer Therapeutics Market Overview
9.2.2 Europe Prostate Cancer Therapeutics Market Forecasts and Analysis
9.2.3 Europe Prostate Cancer Therapeutics Market Forecasts and Analysis - By Therapy
9.2.4 Europe Prostate Cancer Therapeutics Market Forecasts and Analysis - By Distribution Channel
9.2.5 Europe Prostate Cancer Therapeutics Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Prostate Cancer Therapeutics Market
9.2.5.1.1 Germany Prostate Cancer Therapeutics Market by Therapy
9.2.5.1.2 Germany Prostate Cancer Therapeutics Market by Distribution Channel
9.2.5.2 France Prostate Cancer Therapeutics Market
9.2.5.2.1 France Prostate Cancer Therapeutics Market by Therapy
9.2.5.2.2 France Prostate Cancer Therapeutics Market by Distribution Channel
9.2.5.3 Italy Prostate Cancer Therapeutics Market
9.2.5.3.1 Italy Prostate Cancer Therapeutics Market by Therapy
9.2.5.3.2 Italy Prostate Cancer Therapeutics Market by Distribution Channel
9.2.5.4 Spain Prostate Cancer Therapeutics Market
9.2.5.4.1 Spain Prostate Cancer Therapeutics Market by Therapy
9.2.5.4.2 Spain Prostate Cancer Therapeutics Market by Distribution Channel
9.2.5.5 United Kingdom Prostate Cancer Therapeutics Market
9.2.5.5.1 United Kingdom Prostate Cancer Therapeutics Market by Therapy
9.2.5.5.2 United Kingdom Prostate Cancer Therapeutics Market by Distribution Channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Prostate Cancer Therapeutics Market Overview
9.3.2 Asia-Pacific Prostate Cancer Therapeutics Market Forecasts and Analysis
9.3.3 Asia-Pacific Prostate Cancer Therapeutics Market Forecasts and Analysis - By Therapy
9.3.4 Asia-Pacific Prostate Cancer Therapeutics Market Forecasts and Analysis - By Distribution Channel
9.3.5 Asia-Pacific Prostate Cancer Therapeutics Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Prostate Cancer Therapeutics Market
9.3.5.1.1 Australia Prostate Cancer Therapeutics Market by Therapy
9.3.5.1.2 Australia Prostate Cancer Therapeutics Market by Distribution Channel
9.3.5.2 China Prostate Cancer Therapeutics Market
9.3.5.2.1 China Prostate Cancer Therapeutics Market by Therapy
9.3.5.2.2 China Prostate Cancer Therapeutics Market by Distribution Channel
9.3.5.3 India Prostate Cancer Therapeutics Market
9.3.5.3.1 India Prostate Cancer Therapeutics Market by Therapy
9.3.5.3.2 India Prostate Cancer Therapeutics Market by Distribution Channel
9.3.5.4 Japan Prostate Cancer Therapeutics Market
9.3.5.4.1 Japan Prostate Cancer Therapeutics Market by Therapy
9.3.5.4.2 Japan Prostate Cancer Therapeutics Market by Distribution Channel
9.3.5.5 South Korea Prostate Cancer Therapeutics Market
9.3.5.5.1 South Korea Prostate Cancer Therapeutics Market by Therapy
9.3.5.5.2 South Korea Prostate Cancer Therapeutics Market by Distribution Channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Prostate Cancer Therapeutics Market Overview
9.4.2 Middle East and Africa Prostate Cancer Therapeutics Market Forecasts and Analysis
9.4.3 Middle East and Africa Prostate Cancer Therapeutics Market Forecasts and Analysis - By Therapy
9.4.4 Middle East and Africa Prostate Cancer Therapeutics Market Forecasts and Analysis - By Distribution Channel
9.4.5 Middle East and Africa Prostate Cancer Therapeutics Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Prostate Cancer Therapeutics Market
9.4.5.1.1 South Africa Prostate Cancer Therapeutics Market by Therapy
9.4.5.1.2 South Africa Prostate Cancer Therapeutics Market by Distribution Channel
9.4.5.2 Saudi Arabia Prostate Cancer Therapeutics Market
9.4.5.2.1 Saudi Arabia Prostate Cancer Therapeutics Market by Therapy
9.4.5.2.2 Saudi Arabia Prostate Cancer Therapeutics Market by Distribution Channel
9.4.5.3 U.A.E Prostate Cancer Therapeutics Market
9.4.5.3.1 U.A.E Prostate Cancer Therapeutics Market by Therapy
9.4.5.3.2 U.A.E Prostate Cancer Therapeutics Market by Distribution Channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Prostate Cancer Therapeutics Market Overview
9.5.2 South and Central America Prostate Cancer Therapeutics Market Forecasts and Analysis
9.5.3 South and Central America Prostate Cancer Therapeutics Market Forecasts and Analysis - By Therapy
9.5.4 South and Central America Prostate Cancer Therapeutics Market Forecasts and Analysis - By Distribution Channel
9.5.5 South and Central America Prostate Cancer Therapeutics Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Prostate Cancer Therapeutics Market
9.5.5.1.1 Brazil Prostate Cancer Therapeutics Market by Therapy
9.5.5.1.2 Brazil Prostate Cancer Therapeutics Market by Distribution Channel
9.5.5.2 Argentina Prostate Cancer Therapeutics Market
9.5.5.2.1 Argentina Prostate Cancer Therapeutics Market by Therapy
9.5.5.2.2 Argentina Prostate Cancer Therapeutics Market by Distribution Channel

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. PROSTATE CANCER THERAPEUTICS MARKET, KEY COMPANY PROFILES
11.1. VALENT PHARMACEUTICALS LLC
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. BAYER AG
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. ASTRAZENECA
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. SANOFI AVENTIS
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. IPSEN
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. ASTELLA PHARMAINC
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. BRISTOL-MYERS SQUIBB
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. PFIZER INC
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. TEVA PHARMACEUTICAL INDUSTRIES LTD
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. ABBOTT LABORATORIES
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX

12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Valent Pharmaceuticals LLC
2. Bayer AG
3. Astrazeneca
4. Sanofi Aventis
5. IPSEN
6. Bristol-Myers Squibb
7. Astellas Pharma Inc
8. Pfizer Inc
9. Teva Pharmaceutical Industries Ltd
10. Abbott Laboratories
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book